1. Kanda, Tatsuo, Jiang, Xia, Nakamoto, Shingo, Wu, Shuang, Yokosuka, Osamu. 2013. Different effects of three interferons L on Toll-like receptor-related gene expression in HepG2 cells. In Cytokine, 64, 577-83. doi:10.1016/j.cyto.2013.08.010. https://pubmed.ncbi.nlm.nih.gov/24041672/
2. Zhang, Miao-Qing, Zhao, Qiong, Zhang, Jing-Pu. 2020. A new transcription factor ATG10S activates IFNL2 transcription by binding at an IRF1 site in HepG2 cells. In Autophagy, 16, 2167-2179. doi:10.1080/15548627.2020.1719681. https://pubmed.ncbi.nlm.nih.gov/31996071/
3. Wang, Zhen Zhen, Wen, Xiao Ling, Wang, Na, Gao, Xiao Ling, Wang, Hong Jiu. 2023. Portraying the dark side of endogenous IFN-λ for promoting cancer progression and immunoevasion in pan-cancer. In Journal of translational medicine, 21, 615. doi:10.1186/s12967-023-04453-4. https://pubmed.ncbi.nlm.nih.gov/37697300/
4. Lee, Mei-Hsuan, Yang, Hwai-I, Lu, Sheng-Nan, Yuan, Yong, Chen, Chien-Jen. 2015. Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk. In Scientific reports, 5, 17030. doi:10.1038/srep17030. https://pubmed.ncbi.nlm.nih.gov/26602024/
5. Jarret, Abigail, McFarland, Adelle P, Horner, Stacy M, Gale, Michael, Savan, Ram. 2016. Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling. In Nature medicine, 22, 1475-1481. doi:10.1038/nm.4211. https://pubmed.ncbi.nlm.nih.gov/27841874/
智鼠故事 
